Navigation Links
Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus
Date:11/9/2007

- Sustained improvement in disease activity observed through 2.5 years of

LymphoStat-B therapy in a Phase 2 continuation trial - - No observed increase in rates of adverse events, serious adverse events, malignancies and infections over 2.5 years of LymphoStat-B treatment -

ROCKVILLE, Md., Nov. 9 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced the presentation of Phase 2 clinical results demonstrating that LymphoStat-B(R) (belimumab) achieved a sustained improvement in disease activity across multiple clinical measures, decreased the frequency of disease flares over time, and was well tolerated through 2.5 years on treatment in combination with standard of care in patients with active systemic lupus erythematosus (SLE). The results will be the subject of an oral presentation today in Boston at the Annual Scientific Meeting of the American College of Rheumatology (ACR).

(Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO )

"SLE is a chronic disease, and patients need new therapies that provide durable efficacy with a favorable safety profile," said Michelle A. Petri, M.D., M.P.H., Professor, Division of Rheumatology, Department of Medicine, Johns Hopkins University. "The Phase 2 results presented at ACR showed that the significant clinical benefit observed for LymphoStat-B in serologically active SLE patients at 52 weeks appears to be sustained through 2.5 years. We look forward to further evaluation of LymphoStat-B in larger Phase 3 studies, which are ongoing."

A separate poster presentation of the safety profile of LymphoStat-B showed that LymphoStat-B wa
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) today ... the fourth quarter and full year ended December 31, ... for PTC. We are now a growing commercial-stage biopharma ... the rare disease space," stated Stuart W. Peltz, Ph.D., ... to bring the first treatment for Duchenne muscular dystrophy ...
(Date:2/27/2015)... , Feb. 27, 2015  Uroplasty, Inc. (NASDAQ: ... manufactures and markets innovative proprietary products to treat voiding ... 27th Annual ROTH Conference on Tuesday, March 10, 2015. ... Brett Reynolds , Chief Financial Officer, will present at ... on one at the conference at the Ritz Carlton ...
(Date:2/27/2015)... 2015  Two mass spectrometry technologies MALDI ... their effectiveness is established, according to biotechnology ... says that while mass spectrometry (mass spec ... in proteomic biomarker discovery and validation, mass ... techniques has struggled to elucidate molecular distribution ...
Breaking Medicine Technology:PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Uroplasty to Participate in the 27th Annual ROTH Conference 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3
... 81408, the Optical Workers Union that represents associates at ... strike on Sunday, Jan. 22. Approximately 115 employees are ... international union (IUE/CWA) has not endorsed the strike. ... of what we believe to be a contract that ...
... January 23, 2012 Leading hospital for ... for virtually unlimited imaging Arizona Heart, one ... treatment of heart and vascular disease, has opted for ... suites. The Ziehm Vision RFD hybrid edition delivers distortion-free, ...
Cached Medicine Technology:Davis Vision's Newtown Square Lab Employees Authorize Strike; Company Pledges to Fulfill Eyeglass Orders Without Service Interruption 2Arizona Heart: Three Advanced Technology Operating Rooms With State-of-the Art C-arm Solutions 2
(Date:2/28/2015)... 28, 2015 A case management conference ... that have been filed by law firms including Bernstein ... in March, the Firm notes. , According to ... in the federal litigation will meet on March 13, ... prescription therapy treatments designed to raise levels of the ...
(Date:2/28/2015)... Ohio (PRWEB) February 28, 2015 ... Motivational? Supportive? Strategic? , There are all kinds ... strengths. To raise awareness of the advantages and ... firm PeopleKeys is launching a new product this ... clients better understand the connection between personality type, ...
(Date:2/28/2015)... The noted Friedman Dental Group of South ... relaunched their website. The new version of the site ... new section about their team members. Potential and current ... of each Friedman Dental Group team member including new ... to provide our patients with the opportunity to get ...
(Date:2/28/2015)... 28, 2015 Developers of FCPX ... new overlay plugin for Final Cut Pro X entitled FCPX ... Overlay Chromatic gives users total control over 6k lens dirt ... of Pixel Film Studios. “FCPX Overlay Chromatic was professionally designed ... use interface.” , FCPX Overlay Chromatic Grunge 6K is a ...
(Date:2/28/2015)... “ Powermod ” was featured on NewsWatch as ... at the latest and coolest technology products and services available ... a technology expert, conducted the review and shared with viewers ... Getting stuck with a low battery and no way to ... face on a daily basis. Even when a person does ...
Breaking Medicine News(10 mins):Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 4Health News:PeopleKeys Launches The Leadership Report 2Health News:PeopleKeys Launches The Leadership Report 3Health News:Friedman Dental Group Announces Their Updated Website 2Health News:Pixel Film Studios released a new overlay plugin entitled FCPX Overlay Chromatic Grunge 6K exclusively for Final Cut Pro X users 2Health News:Solutions to Keep Phones Charged were Featured on NewsWatch Television on January 29, 2015 2
... A major research company with expertise in managing clinical ... Medical Campus to more efficiently bring the latest stem ... formally known as the Colorado Prevention Center, officially moved ... from the campus on Friday., It is the ...
... poor judges of their patients, health beliefs, according to ... A&M University and Paul Haidet from The Pennsylvania State ... is better the more patients are involved by asking ... for care. Their analysis 1 of how ...
... undergo cardiopulmonary bypass (CPB) during surgery for less ... suffer any impairments in neurocognitive abilities, such as ... Researchers from The Children,s Hospital of Philadelphia, in ... Pediatrics , reported on neuropsychological effects after surgery ...
... , , , , ... AUDIO: Scientists at Washington University School of Medicine in St. ... Click here for more information. , , ... , , , , , , ...
... Gardner HealthDay Reporter , THURSDAY, July 22 (HealthDay ... favorite pastimes -- sitting around -- the shorter their average ... remained even after researchers factored out obesity or the level ... a study of more than 120,000 American adults. It,s ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, July ... face a greater risk of having a stillborn child if ... treatments, a new study finds. Although neither boys nor ... that might affect their offspring, radiation damage to the uterus ...
Cached Medicine News:Health News:University of Colorado joins with major research firm to partner on stem cell research 2Health News:Doctors don't 'get' their patients 2Health News:Heart bypass for uncomplicated heart surgery does not reduce neurocognitive function in children 2Health News:Inhibiting fatty acids in immune cells decreases atherosclerosis risk 2Health News:Inhibiting fatty acids in immune cells decreases atherosclerosis risk 3Health News:Inhibiting fatty acids in immune cells decreases atherosclerosis risk 4Health News:The Longer You Sit, the Shorter Your Life Span: Study 2Health News:Radiation for Childhood Cancer Can Boost Risk of Stillbirth Later 2Health News:Radiation for Childhood Cancer Can Boost Risk of Stillbirth Later 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: